pharma news

News

Five projects share £100m UK-US Cancer Grand Challenges fund

Five scientific teams will receive up to £20m each in a new round of funding under the UK and US Cancer Grand Challenges initiative.

News

Moderna agrees $950m settlement of mRNA jab litigation

Moderna's settlement of patent litigation with Arbutus and Genevant over technology used in its Spikevax COVID vaccine could reach up to $2.25bn.

News

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug

Kyowa Kirin has terminated all clinical trials of its anti-OX40L antibody rocatinlimab, after cases of cancer were seen in patients taking the drug.

News

FDA ramps up its pushback against compounded GLP-1s

In a move that will please Novo Nordisk and Eli Lilly, the FDA sent warnings to 30 telehealth firms, accusing them of illegally marketing GLP-1 drugs.

News

UK puts £50m behind expanded clinical trials drive

The UK has awarded nearly £50m in funding for equipment to help the NHS carry out commercial clinical trials, with a focus on primary care capacity.

News

Loudspeaker used by a man, graphic art representation

'Dismal' survival demands change in bile duct cancer therapy

International cancer experts have called for big changes to bile duct cancer, which kills three-quarters of patients within a year of diagnosis.

Five projects share £100m UK-US Cancer Grand Challenges fund

Moderna agrees $950m settlement of mRNA jab litigation

Cancer risk scuppers Kyowa Kirin's autoimmune disease drug

FDA ramps up its pushback against compounded GLP-1s

UK puts £50m behind expanded clinical trials drive

'Dismal' survival demands change in bile duct cancer therapy

Ipsen' Bylvay fluffs its lines in biliary atresia trial

Discover a new era of healthcare panel engagement: Grounded ...

pharma news

Editor's Picks